The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment failures and improving quality of life. This breakthrough marks a significant advancement after 50 years of stagnant treatment options.

For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have shown that a drug called benralizumab is effective at treating acute attacks of both asthma and chronic obstructive pulmonary disease (COPD),

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.

Benralizumab, the first new treatment for asthma and chronic obstructive pulmonary disease (COPD), is being called a ‘game-changer’ by researchers. Initially reserved for severe cases, new studies sug

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found.

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30 per cent, according to a study.